jRCT2080224074已完成3 期
Phase III study of BK1304 in healthy adults and adolescents
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 入组人数
- 1,500
- 试验地点
- 1
- 主要终点
- -
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 干预模型
- Observer-blind
- 主要目的
- Prevention Purpose
入排标准
- 年龄范围
- 13age old over 至 64age old under（—）
- 性别
- All
入选标准
- •Written informed consent is obtained from subject/legal guardian
排除标准
- •Received BK1304 or intranasal administration of an inactivated influenza virus vaccine
- •History of influenza virus infection or influenza vaccination within 180 days prior to the first dose of study drug
- •History of anaphylaxis to food or drug
- •Judged ineligible for the study by investigator
结局指标
主要结局
-
efficacy Influenza prevention effect(Vaccine Efficacy)
次要结局
未报告次要终点
研究者
研究点 (1)
Loading locations...
相似试验
已完成
3 期
Phase III study of BK1304 in healthy adults and adolescentsPrevention of influenzaJPRN-jRCT2080224074The Research Foundation for Microbial Diseases of Osaka University1,500
未知
2 期
Phase II study of BK1304 in healthy adultsPrevention of influenzaJPRN-jRCT2080223352The Research Foundation For Microbial Diseases Of Osaka University600
已完成
不适用
Phase 2 study of BK1304 in healthy childrenjRCT2031200156The Research Foundation for Microbial Diseases of Osaka University120
已完成
2 期
Phase 2 study of BK1304 in healthy childrePrevention of influenzaJPRN-jRCT2031200156Fuji Hideyuki120
招募中
1 期
A clinical study of MK-1403 in healthy men (MK-1403-004)Atherosclerosis2024-514629-52-00Merck Sharp & Dohme LLC32